Stories are powerful things. And for 18 years, Spencer Stuart, the blue-chip executive search giant, has released its CMO Tenure Study, which has become a de facto State of the Union of chief ...

Editas Medicine has decided to end the development of its gene-editing therapy for thalassaemia and sickle cell disease (SCD), narrowing its R&D focus and making sweeping cuts to its workforce. After ...